The impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: a systematic review.
Breast density
Legislation
Mammography
Notification
Supplemental screening
Journal
Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
21
12
2020
accepted:
17
03
2021
pubmed:
29
3
2021
medline:
24
6
2021
entrez:
28
3
2021
Statut:
ppublish
Résumé
Dense breast tissue is an independent risk factor for breast cancer and lowers the sensitivity of screening mammography. Supplemental screening with ultrasound or MRI improves breast cancer detection rate but has potential harms. Breast density notification (BDN) legislation has been introduced in the United States (US) and its impact on supplemental screening practice is unclear. This study systematically reviewed current evidence to explore the impact of BDN on supplemental screening practice in the US. Medline, PubMed, Embase, Cochrane and the Cinhal Library databases were searched (2009-August 2020). Studies were assessed for eligibility, data were extracted and summarised, and study quality was evaluated. Evidence from the included studies (n = 14) predominantly showed that BDN legislation increased the overall utilisation of supplemental screening by 0.5-143%. This effect was amplified if the notification included a follow-up telephone call informing women about additional screening benefits, and if the state's law mandated insurance cover for supplemental screening. Likelihood of supplemental screening was also influenced by history of breast biopsy and family history of breast cancer, race, age, socioeconomic status, density category, and physician's specialty and region. Some studies reported increases in biopsy rate (up to 4%) and cancer detection rate (up to 11%) after implementation of BDN legislation. BDN leads to increased use of supplemental screening. This has implications for women and the health system. These findings can help inform current and future screening programs, where breast density notification is currently implemented or being considered.
Identifiants
pubmed: 33774734
doi: 10.1007/s10549-021-06203-w
pii: 10.1007/s10549-021-06203-w
doi:
Types de publication
Journal Article
Review
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
11-30Subventions
Organisme : National Health and Medical Research Council
ID : 1194410
Références
Breast Imaging Reporting and Data System. https://www.acr.org/Clinical-Resources/Reporting-and-Data-Systems/Bi-Rads . Accessed 17 Nov 2020
Sprague BL, Gangnon RE, Burt V, Trentham-Dietz A, Hampton JM, Wellman RD, Kerlikowske K, Miglioretti DL (2014) Prevalence of mammographically dense breasts in the United States. J Natl Cancer Inst. https://doi.org/10.1093/jnci/dju255
doi: 10.1093/jnci/dju255
pubmed: 25255803
pmcid: 4271026
Kolb TM, Lichy J, Newhouse JH (2002) Comparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluations. Radiology 225:165–175
pubmed: 12355001
Freer PE (2015) Mammographic breast density: impact on breast cancer risk and implications for screening. Radiographics 35:302–315
pubmed: 25763718
Wolfe JN (1976) Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer 37:2486–2492
pubmed: 1260729
Butler RS, Hooley RJ (2020) Screening breast ultrasound: update after 10 years of breast density notification laws. Am J Roentgenol 214:1424–1435
Cappello NM, Richetelli D, Lee CI (2019) The impact of breast density reporting laws on women’s awareness of density-associated risks and conversations regarding supplemental screening with providers. J Am Coll Radiol 16:139–146
pubmed: 30287178
Vourtsis A, Berg WA (2019) Breast density implications and supplemental screening. Eur Radiol 29:1762–1777
pubmed: 30255244
Gareth ED, Nisha K, Yit L et al (2014) MRI breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat 145:663–672
pubmed: 24687378
Kuhl CK, Strobel K, Bieling H, Leutner C, Schild HH, Schrading S (2017) Supplemental breast MR imaging screening of women with average risk of breast cancer. Radiology 283:361–370
pubmed: 28221097
Berg WA, Zhang Z, Lehrer D et al (2012) Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA 307:1394–1404
pubmed: 22474203
pmcid: 3891886
Berg WA, Blume JD, Cormack JB et al (2008) Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA 299:2151–2163
pubmed: 18477782
pmcid: 2718688
Lee JM, Arao RF, Sprague BL, Kerlikowske K, Lehman CD, Smith RA, Henderson LM, Rauscher GH, Miglioretti DL (2019) Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Intern Med 179:658–667
pubmed: 30882843
pmcid: 6503561
Hooley RJ, Greenberg KL, Stackhouse RM, Geisel JL, Butler RS, Philpotts LE (2012) Screening US in patients with mammographically dense breasts: initial experience with Connecticut public act 09–41. Radiology 265:59–69
pubmed: 22723501
Sprague BL, Stout NK, Schechter C et al (2015) Potential impact of legislation mandating breast density notification: benefits, harms, and cost effectiveness of supplemental ultrasound screening. Ann Intern Med 162:157–166
pubmed: 25486550
pmcid: 4314343
Manning M, Albrecht TL, Yilmaz-Saab Z, Penner L, Norman A, Purrington K (2017) Explaining between-race differences in African-American and European-American women’s responses to breast density notification. Soc Sci Med 195:149–158
pubmed: 29102420
pmcid: 6136892
Dench EK, Darcey EC, Keogh L, McLean K, Pirikahu S, Saunders C, Thompson S, Woulfe C, Wylie E, Stone J (2020) Confusion and anxiety following breast density notification: fact or fiction? J Clin Med 9:955
pmcid: 7230559
Melnikow J, Fenton JJ, Whitlock EP, Miglioretti DL, Weyrich MS, Thompson JH, Shah K (2016) Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. preventive services task force. Ann Intern Med 164:268–278
pubmed: 26757021
pmcid: 5100826
Critical-appraisal-tools - Critical Appraisal Tools | Joanna Briggs Institute. https://joannabriggs.org/critical-appraisal-tools . Accessed 27 Oct 2020
Schünemann HJ, Oxman AD, Higgins JP, Vist GE, Glasziou P, Guyatt GH (2008) Presenting results and ‘summary of findings’ tables. Cochrane handbook for systematic reviews of interventions. John Wiley and Sons Ltd, Chichester, UK, pp 335–357
Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. https://doi.org/10.1136/bmj.b2700
doi: 10.1136/bmj.b2700
pubmed: 19622552
pmcid: 2714672
Aripoli A, Fountain K, Winblad O, Gatewood J, Hill J, Wick JA, Inciardi M (2017) Supplemental screening with automated breast ultrasound in women with dense breasts: comparing notification methods and screening behaviors. Am J Roentgenol 210:W22–W28
Manning M, Albrecht TL, O’Neill S, Purrington K (2019) Between-race differences in supplemental breast cancer screening before and after breast density notification law. J Am Coll Radiol 16:797–803
pubmed: 30342908
Mason C, Yokubaitis K, Howard E, Shah Z, Wang J (2015) Impact of Henda’s law on the utilization of screening breast magnetic resonance imaging. Proc (Bayl Univ Med Cent) 28:7–9
Parris T, Wakefield D, Frimmer H (2013) Real world performance of screening breast ultrasound following enactment of Connecticut bill 458. Breast J 19:64–70
pubmed: 23240937
Ram S, Sarma N, López JE, Liu Y, Li C-S, Aminololama-Shakeri S (2018) Impact of the California breast density law on screening breast MR utilization, provider ordering practices, and patient demographics. J Am Coll Radiol 15:594–600
pubmed: 29622173
Sobotka J, Hinrichs C (2015) Breast density legislation: discussion of patient utilization and subsequent direct financial ramifications for insurance providers. J Am Coll Radiol 12:1011–1015
pubmed: 26163978
Chau SL, Alabaster A, Luikart K, Brenman LM, Habel LA (2017) The effect of California’s breast density notification legislation on breast cancer screening. J Prim Care Community Health 8:55–62
pubmed: 27799412
Nyante SJ, Marsh MW, Benefield T, Earnhardt K, Lee SS, Henderson LM (2020) Supplemental breast imaging utilization after breast density legislation in North Carolina. J Am Coll Radiol 17:6–14
pubmed: 31271735
Sanders LM, King AB, Goodman KS (2016) Impact of the new jersey breast density law on imaging and intervention volumes and breast cancer diagnosis. J Am Coll Radiol 13:1189–1194
pubmed: 27318582
Aminawung JA, Hoag JR, Kyanko KA, Xu X, Richman IB, Busch SH, Gross CP (2020) Breast cancer supplemental screening: women’s knowledge and utilization in the era of dense breast legislation. Cancer Med 9:5662–5671
pubmed: 32537899
pmcid: 7402830
Liao GJ, Hippe DS, Chen LE, Lee JM, Liao JM, Ramsey SD, Lee CI (2020) Physician ordering of screening ultrasound: national rates and association with state-level breast density reporting laws. J Am Coll Radiol 17:15–21
pubmed: 31326406
Busch SH, Hoag JR, Aminawung JA, Xu X, Richman IB, Soulos PR, Kyanko KA, Gross CP (2019) Association of state dense breast notification laws with supplemental testing and cancer detection after screening mammography. Am J Public Health 109:762–767
pubmed: 30896987
Horný M, Cohen AB, Duszak R, Christiansen CL, Shwartz M, Burgess JF (2020) Dense breast notification laws: impact on downstream imaging after screening mammography. Med Care Res Rev 77:143–154
pubmed: 29347864
Saulsberry L, Pace LE, Keating NL (2019) The impact of breast density notification laws on supplemental breast imaging and breast biopsy. J Gen Intern Med 34:1441–1451
pubmed: 31144277
pmcid: 6667574
Choudhery S, Patel BK, Johnson M, Geske J, Fazzio RT, Lee C, Pruthi S (2020) Trends of supplemental screening in women with dense breasts. J Am Coll Radiol 17:990–998
pubmed: 32105645
Miles R, Wan F, Onega TL et al (2018) Underutilization of supplemental magnetic resonance imaging screening among patients at high breast cancer risk. J Womens Health (Larchmt) 27:748–754
Checka CM, Chun JE, Schnabel FR, Lee J, Toth H (2012) The relationship of mammographic density and age: implications for breast cancer screening. AJR Am J Roentgenol 198:W292-295
pubmed: 22358028
Kang Y-J, Ahn SK, Kim SJ, Oh H, Han J, Ko E (2019) Relationship between mammographic density and age in the United Arab Emirates population. J Oncol 2019:7351350
pubmed: 31467543
pmcid: 6701291
Kyanko KA, Hoag J, Busch SH, Aminawung JA, Xu X, Richman IB, Gross CP (2020) Dense breast notification laws, education, and women’s awareness and knowledge of breast density: a nationally representative survey. J GEN INTERN MED 35:1940–1945
pubmed: 31916210
Manning MA, Duric N, Littrup P, Bey-Knight L, Penner L, Albrecht TL (2013) Knowledge of breast density and awareness of related breast cancer risk. J Cancer Educ 28:270–274
pubmed: 23467999
pmcid: 3794460
Rhodes DJ, Jenkins SM, Hruska CB, Vachon CM, Breitkopf CR (2020) Breast density awareness, knowledge, and attitudes among US women: national survey results across 5 years. J Am Coll Radiol 17:391–404
pubmed: 31756308
Trinh L, Ikeda DM, Miyake KK, Trinh J, Lee KK, Dave H, Hanafusa K, Lipson J (2015) Patient awareness of breast density and interest in supplemental screening tests: comparison of an academic facility and a county hospital. J Am Coll Radiol 12:249–255
pubmed: 25743922
Richman I, Asch SM, Bendavid E, Bhattacharya J, Owens DK (2017) Breast density notification legislation and breast cancer stage at diagnosis: early evidence from the SEER registry. J Gen Intern Med 32:603–609
pubmed: 27844260
Hruska CB, Conners AL, Jones KN, O’Connor MK, Moriarty JP, Boughey JC, Rhodes DJ (2015) Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts. Am J Roentgenol 204:1345–1353
Patel BK, Ridgeway JL, Ghosh K et al (2019) Behavioral and psychological impact of returning breast density results to Latinas: study protocol for a randomized clinical trial. Trials 20:744
pubmed: 31852492
pmcid: 6921571
Smith-Bindman R, Kwan ML, Marlow EC et al (2019) Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000–2016. JAMA 322:843–856
pubmed: 31479136
pmcid: 6724186
Houssami N, Lee C (2018) The impact of legislation mandating breast density notification – review of the evidence. Breast 42:102–112
pubmed: 30236594
pmcid: 6487858